Your browser doesn't support javascript.
loading
ADS-J1 inhibits semen-derived amyloid fibril formation and blocks fibril-mediated enhancement of HIV-1 infection.
Xun, Tianrong; Li, Wenjuan; Chen, Jinquan; Yu, Fei; Xu, Wei; Wang, Qian; Yu, Ruizhe; Li, Xiaojuan; Zhou, Xuefeng; Lu, Lu; Jiang, Shibo; Li, Lin; Tan, Suiyi; Liu, Shuwen.
Afiliación
  • Xun T; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, People's Republic of China.
  • Li W; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, People's Republic of China.
  • Chen J; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, People's Republic of China.
  • Yu F; Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai Medical College and Institute of Medical Microbiology, Fudan University, Shanghai, People's Republic of China.
  • Xu W; Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai Medical College and Institute of Medical Microbiology, Fudan University, Shanghai, People's Republic of China.
  • Wang Q; Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai Medical College and Institute of Medical Microbiology, Fudan University, Shanghai, People's Republic of China.
  • Yu R; School of Public Health and Tropical Medicine, Southern Medical University, Guangzhou, People's Republic of China.
  • Li X; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, People's Republic of China.
  • Zhou X; South China Sea Institute of Oceanology, Chinese Academy of Sciences, Guangzhou, People's Republic of China.
  • Lu L; Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai Medical College and Institute of Medical Microbiology, Fudan University, Shanghai, People's Republic of China.
  • Jiang S; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, People's Republic of China Key Laboratory of Medical Molecular Virology of Ministries of Education and Health, Shanghai Medical College and Institute of Medical Micro
  • Li L; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, People's Republic of China.
  • Tan S; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, People's Republic of China suiyitan@smu.edu.cn liusw@smu.edu.cn.
  • Liu S; Guangdong Provincial Key Laboratory of New Drug Screening, School of Pharmaceutical Sciences, Southern Medical University, Guangzhou, People's Republic of China suiyitan@smu.edu.cn liusw@smu.edu.cn.
Antimicrob Agents Chemother ; 59(9): 5123-34, 2015 Sep.
Article en En | MEDLINE | ID: mdl-26055369
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Semen / Triazinas / Infecciones por VIH / Fármacos Anti-VIH / Amiloide / Naftalenosulfonatos Límite: Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2015 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Semen / Triazinas / Infecciones por VIH / Fármacos Anti-VIH / Amiloide / Naftalenosulfonatos Límite: Humans Idioma: En Revista: Antimicrob Agents Chemother Año: 2015 Tipo del documento: Article Pais de publicación: Estados Unidos